A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers.

NCT07190716 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Single Ascending Dose
Healthy Subjects

Interventions

BIOLOGICAL: GR2301 injection

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.